Form 4: Inspire Medical Director Boosts Stake

Inspire Medical Systems Director Georgia Melenikiotou acquired 229 shares of common stock at $78.84 per share as part of her compensation, increasing her direct beneficial ownership to 3,986 shares.

Summary

• Georgia Melenikiotou, a Director of Inspire Medical Systems, Inc. (INSP), acquired 229 shares of common stock.
• The transaction occurred on October 14, 2025, at a price of $78.84 per share.
• These shares were received in lieu of cash fees, consistent with the Company's Non-Employee Director Compensation Policy.
• Following this acquisition, Ms. Melenikiotou directly beneficially owns 3,986 shares of Inspire Medical Systems common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The acquisition of shares by a director, even as compensation, is generally a neutral to slightly positive signal, indicating alignment of interests and adherence to compensation policies. It's a routine event, not indicative of significant news.

Positives

• A Director increasing their stake in the company, even through compensation, can signal confidence in the company's future prospects.
• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-arranged, non-discretionary acquisition.

Negatives

• No negative aspects are directly indicated by this routine insider transaction filing.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This routine insider transaction does not provide specific details to analyze broader industry trends or competitor performance. It reflects an individual director's equity compensation.

Comparison to Industry Standards

• This filing is a standard disclosure of an insider stock transaction and does not contain information for comparison to global benchmarks, comparable companies, or projects.

Corporate Governance

Related Party Transactions

• The transaction involves a director receiving shares as compensation, which is a standard related-party transaction in the context of executive and director compensation policies.

Stakeholder Impact

• Shareholders: Minor positive impact as director's ownership increases, aligning interests. No direct financial impact on existing share value from this specific transaction.
• Directors: The reporting director's compensation includes equity, aligning her financial interests with the company's performance.

Next Steps

• This filing does not mention any specific future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

Inspire Medical Systems, INSP, Insider Trading, Form 4, Director Stock Acquisition, Georgia Melenikiotou, Equity Compensation, Rule 10b5-1